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Edited by Thomas So¨llnerAbstract Three recent papers have addressed a long-standing
question in exocytosis: how does a sudden calcium inﬂux trigger
a coordinated synchronous release in regulated exocytosis [Gir-
audo, C.G., Eng, W.S., Melia, T.J. and Rothman, J.E. (2006)
A clamping mechanism involved in SNARE-dependent exocyto-
sis. Science 313, 676–680; Schaub, J.R., Lu, X., Doneske, B.,
Shin, Y.K. and McNew, J.A. (2006) Hemifusion arrest by com-
plexin is relieved by Ca2+–synaptotagmin I. Nat. Struct. Mol.
Biol. 13, 748–750; Tang, J., Maximov, A., Shin, O.H., Dai,
H., Rizo, J. and Sudhof, T.C. (2006) A complexin/synaptotag-
min 1 switch controls fast synaptic vesicle exocytosis. Cell 126,
1175–1187]? Using diverse approaches that include cell-free
reconstitution of the membrane fusion machinery and in vivo
manipulation of fusogenic proteins, these groups have established
that the complexin proteins are fusion clamps. By arresting ves-
icle secretion just prior to fusion, complexin primes select vesi-
cles for a fast, synchronous response to calcium.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Forty years ago Katz and colleagues recognized that the cal-
cium-mediated release of acetylcholine occurs in bursts. This
release is fast, with the ﬁrst indications of free neurotransmitter
coming less than 0.2 ms after an action potential invoked cal-
cium inﬂux. The neurotransmitter is packaged into synaptic
vesicles which are morphologically docked and biochemically
primed to fuse, awaiting a calcium-dependent trigger. This
pre-fusion behavior distinguishes synaptic exocytosis from
most constitutive intracellular fusion events in which the vesi-
cles do not accumulate at the target membrane unless some-
thing is done to disrupt the system. Similar vesicle
accumulations are observed in other regulated secretion steps,
including for example, the release of insulin from pancreatic b-
cells.
The basic fusion machinery, the SNARE family of proteins,
is known and is common to both regulated and constitutive*Fax: +1 212 851 5570.
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doi:10.1016/j.febslet.2007.02.066forms of vesicle fusion. Thus an important feature of regulated
exocytosis is that docked vesicles, which have already engaged
the SNARE fusion machinery, do not fuse spontaneously at
any appreciable rate. A natural consequence of selectively
arresting exocytosis at the level of SNARE assembly is that re-
lease can be tightly coupled to the calcium inﬂux, such that
otherwise rate-limiting steps upstream of SNARE assembly
(like docking) will already be complete.
Much is already known about the proteins involved in the
calcium-dependent regulation. Active zones or granule release
sites are replete with calcium channels providing a high local
and synchronized calcium concentration in response to action
potentials or glucose-dependent depolarizations, respectively.
This calcium inﬂux is in turn detected by proteins called the
synaptotagmins which are the calcium sensors for both the
very fast synchronized exocytosis speciﬁc to synaptic or b-cell
release, and the other slower but still regulated calcium-depen-
dent fusion events throughout the organism (e.g. homotypic
lysosomal fusion). What constitutes the clamp that arrests ves-
icles in the synchronous release pool, and how this clamp re-
sponds to calcium-binding at synaptotagmin have until
recently been unknown. This review will brieﬂy summarize
what has long been known about the basic fusion machinery
(the SNAREs) and the calcium sensor (synaptotagmin), and
then explore in depth how complexin interacts with the
SNAREs and synaptotagmin to clamp fusion at a late step
in SNARE assembly.2. SNARE-mediated membrane fusion
Any mechanism designed to arrest exocytosis at a very late
stage of secretion must ultimately target the fusion machinery.
The SNARE family of proteins directs the fusion of vesicles
with target membranes throughout the cell [4]. Three SNAREs
drive calcium-mediated exocytosis at the synapse and a hand-
ful of other granular release steps: VAMP2/synaptobrevin is
found on the vesicle membrane (v-SNARE) and the complex
of syntaxin 1 and SNAP-25 deﬁnes release sites on the target
membrane (t-SNARE) [5]. The central role of this complex
in exocytosis has been established by many experimental par-
adigms, including genetic knockout, neurotoxin-mediated pro-
teolytic cleavage, introduction of dominant-negative inhibitory
fragments, and overexpression of mutant/modiﬁed SNARE
constructs (reviewed in [6,7]). Toxin or antibody-directed
manipulation of SNARE complexes eliminates the fastestblished by Elsevier B.V. All rights reserved.
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SNAREs continue to be functionally important at a very late
step in the fusion process. Furthermore, site-directed mutants
of the syntaxin trans-membrane domain alter the rate of neu-
rotransmitter eﬄux, suggesting that the SNARE trans-mem-
brane domains themselves may line the fusion pore [8].
In vitro, extensive biochemistry and protein biophysics have
revealed much about the mechanism underlying SNARE func-
tion (reviewed in [6,7]). Helical stretches of about 70 amino
acids (SNARE domains) serve as the primary SNARE–
SNARE interaction surfaces. Separate SNAREs anchored on
the vesicle and target membranes interact via the amino-termi-
nal (membrane distal) portions of the SNARE-domains
to initiate the fusion reaction. These partially-assembled
membrane-bridging complexes are called SNAREpins [9] (or
trans-SNAREs) (Fig. 1). Each SNAREpin is composed of four
SNARE domains, three from the target membrane SNARE
(t-SNARE) and one from the vesicle-membrane SNARE (v-
SNARE). The progressive amino-to-carboxyl assembly of these
four helices into a SNARE coiled-coil brings the membranes
into close apposition and ultimately drives fusion (Fig. 1).
The post-fusion, fully assembled four-helix bundle (the cis-
SNARE complex) is a highly stable structure requiring energy
(in the form of ATP-driven NSF activity) for disassembly, after
which the individual SNAREs can be recycled to their appro-
priate compartments for the next round of exocytosis [10].
Although many proteins inﬂuence the rate and extent of exo-
cytosis in vivo, SNAREs alone are fully suﬃcient to drive
membrane fusion. The ﬁrst demonstration of this principle
came from the fusion of liposomes reconstituted with the syn-
aptic SNARE proteins [9] (Fig. 2). Variations of this assay
have now been used by nearly a dozen independent groups
to explore the consequences of speciﬁc mutations, altered lipid
composition, SNARE speciﬁcity, and the eﬀect of regulatory
factors on this reaction. In vitro, reconstituted SNAREs begin
to assemble between liposomes quickly, via sequences over the
amino-terminal half of the SNARE domain [11]. If fusion isFig. 1. SNARE cycle. During exocytosis, the SNAREs progress from free
SNAREpins to highly stable post-fusion cis-SNARE assemblies. Regulator
SNAREpin intermediates to inﬂuence the rate and reversibility of fusion.blocked artiﬁcially, by introducing lipids which prevent signif-
icant membrane curvature, these semi-assembled protein com-
plexes accumulate [12]. These complexes are substrates for
botulinum toxin B but not tetanus toxin, indicating that recon-
stituted SNAREs can mimic physical aspects of the pre-fusion
(pre-calcium inﬂux) state observed in vivo [13].
More recently, a second assay has been developed (Fig. 2), in
which the normally cytosol-facing SNARE proteins are ectop-
ically expressed on the surface of cells to drive whole-cell fu-
sion [14]. Thus SNAREs are eﬃcient fusogens even in large
biologically complex cellular membranes.
These two systems explore diﬀerent energy landscapes in the
fusion reaction, but share many important commonalities
including two which bear directly on the question of regulated
exocytosis: (1) Relative to regulated exocytosis, SNARE fusion
is inherently slow in vitro. In part, this reﬂects a slow activa-
tion step of the t-SNARE complex, whereby regulatory regions
at the amino terminus and the membrane interface must un-
dergo conformational changes prior to or during assembly
with the v-SNARE [11,15]. These regulatory regions are prob-
ably common to all SNARE processes, and thus are likely con-
trolled by ubiquitous SNARE-associated regulatory factors,
like the Sec1/Munc18 family of proteins [16]. But to a large de-
gree, this apparent slowness reﬂects the kinetics of a popula-
tion, where the ﬁrst events may occur in milliseconds or less,
but the halftime of the whole population may be orders of
magnitude longer [15]. In short, this is a problem of synchro-
nicity. (2) SNARE fusion is inherently calcium-insensitive
[17]. Together, these problems indicate a crucial role for addi-
tional factors in calcium-mediated fusion.3. The calcium sensor
Among the many calcium-binding proteins localized to syn-
aptic active zones, synaptotagmin is now well-described as the
primary calcium sensor for SNARE-dependent fusion (re-v- and t-SNAREs through membrane-bridging intermediates termed
y factors, including the calcium machinery, are likely to act upon the
Fig. 2. Reconstituted fusion assays. Top: In the liposome assay [9], SNAREs are inserted into liposomes of deﬁned lipid composition. The v-
liposomes carry two ﬂuorescent lipids, rhodamine (pink circles) and NBD (yellow circles) at a high surface density such rhodamine quenches the
NBD. Fusion of labeled and unlabeled liposomes reduces the surface density, leading to NBD ﬂuorescence. Bottom: In the ﬂipped-SNARE assay
[14], the SNAREs are expressed on the outside of the cell where none of the usual SNARE-interacting regulatory factors are present, save those that
are speciﬁcally introduced by the experimenter. Fusion results in the cytoplasm of the v-SNARE expressing cell (labeled with dsRed) surrounding the
nucleus of the t-SNARE expressing cell (labeled with ECFP). Components of the calcium machinery can then be added either directly to the fusion
reaction, or can be ‘‘ﬂipped’’ by expressing these proteins in the cell with a signal sequence that will direct them to face outward at the plasma
membrane. In this way, the contributions of complexin or synaptotagmin can be assessed without confounding eﬀects from other protein–protein
interactions.
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gral membrane proteins with two cytosol-facing calcium-bind-
ing C2 domains [19]. The C2 domains preferentially associate
with diﬀerent lipids in a calcium-dependent manner and also
mediate calcium-dependent interactions with the SNAREs
(e.g. [20–23] but see [6,7] for many more), consistent with a late
role in fusion. Knockout of mouse synaptotagmin I abolishes
the fast synchronous component of calcium-mediated release
[24]. Furthermore, mutations of synaptotagmin reduce or elim-
inate the apparent cooperativity of calcium in exocytosis, alter
the vesicle release probability, and shift the calcium sensitivity
[25,26].
How synaptotagmin imparts calcium-sensitivity upon the
fusion machinery is an ongoing area of research. In vitro, lipo-
some fusion assays support both negative and positive roles for
synaptotagmin. In the absence of calcium, synaptotagmin I
suppresses SNARE-mediated fusion about 30–50% (depending
upon SNARE and synaptotagmin densities) [27]. While this
falls short of the persistent fusion clamp observed prior to cal-
cium inﬂux in vivo, it indicates that calcium-free synaptotag-
min can favor the development of a clamped-intermediate.
Upon addition of calcium, synaptotagmin I enhances
SNARE-mediated liposome fusion in a SNARE and lipid-spe-
ciﬁc fashion [27–29], suggesting an active role in driving
SNARE assembly or lipid perturbation.
From these studies and many others we can conclude that
synaptotagmin is the calcium sensor involved in the calcium-
dependent synchronous release, and probably acts upon or
within the prefusion clamped state to accelerate a late step in
fusion. This acceleration likely involves either SNARE assem-bly or membrane reorganization (or both). Alone however,
calcium-free synaptotagmin is a poor (at best) clamping pro-
tein, indicating the involvement of one or more other factors
in the fusion arrest.4. Complexin regulates evoked release
Synaptotagmin function appears to be intimately associated
with the complexin family of proteins. Complexins are soluble
proteins which do not bind calcium but nonetheless modulate
calcium-mediated release [30]. Overexpression, injection or
knockdown of cellular complexin levels reduces evoked exocy-
tosis [31–35], which, like synaptotagmin, can often be rescued
at higher calcium concentrations [34]. Double knockout of two
isoforms of complexin found in hippocampal neurons results
in a phenotype very similar to the synaptotagmin knockout;
synchronous release is abolished and calcium sensitivity is dra-
matically shifted to higher calcium [36].
There are four known complexin isoforms in mammals, with
distinct but overlapping cellular expression patterns. Com-
plexin I is brain-speciﬁc [30,37–39] (with some expression in
pancreatic islets as well [33]), II is brain-speciﬁc with some
weak expression in other tissues [30,38,39], III is brain-speciﬁc
but highly enriched in the retina and cerebral cortex [37] and
IV is retina-speciﬁc [37]. Cells may express more than one iso-
form, for example, pyramidal cells of the rat hippocampus ex-
press the mRNAs of complexins I, II and III [37].
The isoforms comprise two subfamilies (complexin I/II vs.
III/IV) with weak identity between families (24–28%) but high
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served from mouse to human (>90% identity), consistent with
a critical, evolutionarily conserved function. The subfamilies
are distinguished by structural elements at the amino and car-
boxyl termini in the primary sequence: an N-terminal helix
found in the I/II family is partially disrupted by a 10–12 amino
acid insertion in the III/IV family, and the I/II family contains
a C-terminal cluster of basic residues instead of a membrane-
anchoring CAAX box found in the III/IV family (Fig. 3).
Despite their diﬀerences, all four isoforms can rescue the
evoked release defect in the I/II double knockout [36,37] indi-
cating a high level of functional redundancy. Likewise, overex-
pression of either complexin I or II reduces exocytosis of small
synaptic-like vesicles in PC12 cells [32]. On the other hand, re-
lease from dense core granules in PC12 cells shows some mea-
sure of complexin selectivity, where overexpression of
complexin II but not complexin I cuts the number of release
events approximately in half [40].
Complexins also play a role in calcium-dependent regulated
exocytosis from non-neuronal and neuroendocrine cells.
Manipulation of complexin levels reduces glucose-induced
secretion in pancreatic b-cells [33], antigen-induced degranula-
tion from rat mast cells [34], and PKA dependent plasma-
membrane expression of sodium channels in epithelial cells
[41]. As both ribbon synapses in the retina and mast cell secre-
tion involve a subset of SNARE proteins that are distinct fromFig. 3. Complexin structure. (A) Each complexin family is deﬁned by a
central SNARE-binding helix about 40 amino acids long (red), across
which the sequences are highly conserved. The C-terminus of the III/IV
family carries a CAAX box for isoprenylation. (B) Crystal structure of
the conserved SNARE-binding central helix of complexin (red) bound
to the SNARE core domains [59]. Notably, the most N-terminal
(membrane-proximal) portion of the helix is bent away from the
SNARE coiled-coil. Structures were rendered with the PyMol
software.those found in most synapses, it is likely that the complexin
family can functionally interact with a variety of diﬀerent fu-
sion assemblies.5. Spontaneous release and the fusion clamp
If the primary function of complexin and/or calcium-free syn-
aptotagmin is to arrest an otherwise constitutive fusion process,
one might expect that the removal of one or both components
of that clamp machinery would increase the rate of constitutive
exocytic events [42]. In electrophysiological recordings of cul-
tured neurons, constitutive (spontaneous) fusion events, termed
minis, occur in the absence of an action potential and exhibit
essentially single vesicle release characteristics [43]. These
events are abolished in the absence of syntaxin 1 [44,45], and
are dramatically reduced in the absence of VAMP2 [46], imply-
ing that the same basal fusion machinery likely underlies both
the regulated and constitutive processes (but note the possible
involvement of other SNARE complexes [47,48]).
Genetic-ablation of synaptotagmin has mixed eﬀects on
spontaneous fusion. Early studies in Drosophila revealed that
knockdown or mutation of synaptotagmin does result in an in-
crease in the frequency of minis at the neuromuscular junction
[26,49–51]. However, when the same Drosophila mutants were
interrogated at an earlier stage of larval development, the in-
crease in minis was no longer apparent [52]. In mice, synapto-
tagmin knockouts were initially studied using autaptic
synapses, in which the neuron in question forms a synapse with
itself [24]. These neurons did not show any change in the fre-
quency of minis compared to wild-type controls. Yet, when
the same knockouts (or knockouts of the highly related syn-
aptotagmin 2) were tested with the more physiologically rele-
vant interneuronal synapses, spontaneous release was
increased [53,54], on par with the most robust increases ob-
served in Drosophila. Thus, in both organisms, synaptotagmin
may act to inhibit spontaneous release, but questions regarding
developmental compensation and cell history in these genetic
backgrounds make a more substantive interpretation diﬃcult.
Developmental compensation will always be a concern in
pathways that exhibit signiﬁcant protein or functional redun-
dancy. For example, knockout of either complexin I or com-
plexin II alone from mice has only a mild phenotype [36,55],
with essentially no eﬀect on exocytic release characteristics.
Only the double knockout of complexins I and II leads to a
pronounced decrease in regulated exocytosis (as measured in
autaptic synapses of mouse hippocampal cells) [36]. No eﬀects
on mini frequency have been observed. It will be interesting to
see what happens when interneuronal synapses are considered,
and whether the remaining complexin isotype(s) (complexin
III) in these cells is contributing in a signiﬁcant way. Likewise,
knockouts in Drosophila could be especially revealing, as these
animals carry only a single complexin gene.
Developmental compensation can be avoided by instead
inducing acute changes in protein expression levels. For exam-
ple, viral-mediated introduction of complexin tethered to
VAMP2 not only disrupts calcium-mediated fast release, but
also decreases the spontaneous fusion frequency [3]. Both re-
sults are consistent with a clamping mechanism.
Thus, a vast array of genetic experiments place complexin
and synaptotagmin at the same functional step in synaptic exo-
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Based on these fundamental observations, many groups have
begun to apply biochemistry and reconstitution approaches
to piece together a mechanistic understanding of the fusion
pore regulatory machinery.6. Complexin–SNARE interactions
Complexins were ﬁrst identiﬁed through pull-down assays of
SNARE proteins from brain [30,56], and the subsequent bio-
chemistry is consistent with a direct action of complexin upon
the SNARE complex. Recombinant complexin binds with high
aﬃnity to the fully-assembled neuronal cis-SNARE via an
antiparallel helix-coiled-coil [57–59] (Fig. 2). Weak interactions
between complexin and a syntaxin/SNAP-25 t-SNARE com-
plex have been captured in pull-down experiments [30,35]
but are not observed by ﬂuorescence anisotropy [57] and little
or no interaction is found with individual SNARE components
[22,30,35,60,61]. Thus the functional target for complexin is
likely to be a ternary SNARE complex.
Complexin binds the cis-SNARE complex via a 40 amino
acid central helical domain which nestles into a groove be-
tween syntaxin and VAMP2 [58,59] (Fig. 3). This interaction
is SNARE-speciﬁc: substitution of VAMP8 for VAMP2 essen-
tially eliminates binding [62], while substitution of syntaxin
shows a graded response such that binding to syntaxin
1,3 > 2 > 4 [62] (but see also [63] which suggests the speciﬁcity
may be more absolute). Complexin binding to the cis-SNARE
reduces the rate of deuterium exchange on some amino acids in
the C-terminal third of the VAMP2 SNARE domain, consis-
tent with a role in stabilizing a particular assembly conforma-
tion of the SNARE complex [59]. Binding does not, however,
accelerate the assembly of soluble SNAREs into a tertiary
complex as assessed by either circular dichroism or ﬂuores-
cence anisotropy [57]. The most N-terminal (and therefore
membrane proximal) region of complexin forms a second helix
which bends away from the SNARE complex, while the C-ter-
minal half of the protein exhibits no signiﬁcant stable structure
[62]. Aside from the isoprenylation sites found in the III/IV
family, no clear function has yet been ascribed to the C-termi-
nal half of the protein. When complexin I is bound to mem-
brane-reconstituted cis-SNAREs the C-terminus folds back
upon the SNARE complex such that both the N- and C-ter-
mini may be in close proximity to the membrane [22].
By targeting speciﬁc SNARE interacting residues identiﬁed
in the crystal structures, the importance of complexin–SNARE
complexes could be directly tested in vivo. For example, while
overexpression of complexin II in chromaﬃn cells reduces total
exocytosis by about 50%, overexpression of a point mutant de-
signed to disrupt speciﬁc interactions with VAMP2 is without
eﬀect [64], suggesting that interaction with VAMP2 is a critical
component of complexin function. Thus, the SNARE machin-
ery constitutes a principle site of complexin function in vivo.7. Complexin as the fusion-clamp
In principle, complexin could act through one of two mech-
anisms to instill calcium sensitivity upon the basic SNARE
machinery: (1) Complexin could directly accelerate an other-wise slow step in SNAREpin assembly, presumably in
response to a synaptotagmin-related conformational change,
or (2) complexin could clamp the fusion machinery at a late
stage in assembly, accumulating complexes that are primed
to fuse in response to a subsequent calcium signal. Three dif-
ferent functional assays establish that complexin is a fusion
clamping protein.
Addition of complexin I to a ﬂipped-SNARE cell–cell fusion
assay (Fig. 2) reduces the extent of fusion in a concentration-
dependent manner [1]. The concentrations required are high
(40 lM to achieve 50% inhibition), suggesting that binding
of complexin I to trans-SNAREs is signiﬁcantly less stable
than to cis-SNAREs where kD’s of 10–800 nM have been de-
scribed [22,57]. In order to increase the local concentration of
complexin, Giraudo et al., coupled complexin I to a glycero-
phosphatidylinositol (GPI) lipidic anchor [1]. This GPI–com-
plexin completely inhibited fusion while a point-mutant
designed to interfere with complexin–VAMP2 interactions
was essentially without eﬀect.
The GPI anchor can be removed by phosphatidylinositol–
phospholipase C (PI–PLC) mediated cleavage. Cells grown to-
gether overnight in the presence of GPI–complexin do not
fuse, but addition of PI–PLC in the morning leads to a burst
of fusion, accomplishing in 5 min what otherwise would have
taken several hours. This result, in particular, conﬁrms that
complexin has trapped the fusion machinery at a late stage
of assembly, where it is primed to fuse rapidly upon removal
of the clamp.
In parallel, McNew and colleagues tested other isoforms for
activity in the SNARE liposome assay [2]. Fusion from mam-
malian VAMP2 and syntaxin/SNAP-25 liposomes incubated
together with either mouse complexin IV or Drosophila com-
plexin (Drosophila has only one complexin gene) is inhibited
20–30%. In more extensive studies focusing upon a single iso-
form (the Drosophila complexin), these authors observe a
greater complexin-dependent inhibition with SNAREs from
which the syntaxin N-terminal Habc domain has been removed
(to 40–50% inhibition). It will be interesting to see if this diﬀer-
ence can be exploited to clarify the order of action of proteins
that engage the Habc (for example Munc18-1 [16]) vs. those
that are speciﬁc to calcium regulation. Eventually, experiments
must also address whether Drosophila complexin is truly inter-
changeable with its mammalian counterpart(s) in both this as-
say and in the recovery activities described below, and whether
diﬀerent complexin isoforms from the same species elicit com-
parable functionalities. Inhibition in this assay is SNARE-spe-
ciﬁc (yeast SNAREs are fully resistant to the complexins) and
not sensitive to v-SNARE/t-SNARE or protein/lipid ratios,
consistent with a function targeting only the relatively rare
SNAREpin conformation.
Finally, Tang et al. have developed a novel construct to con-
centrate overexpressed complexin only at sites of exocytosis
and thereby establish the SNARE-directed activities of com-
plexin in vivo: they fused complexin I directly to the N-termi-
nus of VAMP2 [3]. Overexpression of this complexin–VAMP2
construct in wild-type murine cortical neurons potently inhib-
ited exocytosis, consistent with previous studies showing that
excess complexin limits secretion [31,32,64]. The inhibition
was just as robust when the fusion construct contained only
the SNARE-binding helix of complexin fused to VAMP2, indi-
cating no major role for either termini in the exocytosis block.
Furthermore, introduction of several mutations in the
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ing to the SNARE complex completely abrogates the inhibi-
tion phenotype. Thus, in all three systems, complexin acts as
a fusion clamp.8. Calcium-mediated reversal of the clamp: the role of
synaptotagmin
The complexin-clamped SNAREpin assembly is itself cal-
cium-insensitive [1,2]. In the presence of synaptotagmin, how-
ever, calcium induces a rapid release from the clamped state,
such that the rate of fusion is several orders of magnitude fas-
ter than that observed in complexin-free control samples [1,2].
Thus synapotagmin constitutes not only a calcium-sensor, but
also a fusion trigger for the primed complex.
The speed of the calcium-dependent burst is much faster in
the liposome assay (10 s) than in the whole cell assay
(5 min). The source of this diﬀerence is not yet clear, but sev-
eral interesting possibilities can be considered. First in the lipo-
some assay, the SNAREpin may be arrested at a later stage of
fusion pore formation, because the complexin block occurs
after hemifusion of the lipid bilayers [2]. In a hemifused struc-
ture, one leaﬂet from each of the fusing bilayers has merged.
Such a structure is sometimes considered an immediate precur-
sor to fusion pore formation, and would represent a very late
stage in the fusion process. A fraction of all SNARE-mediated
liposome fusion reactions culminate in hemifusion in the ab-
sence of complexin [65], but in the presence of the complexin
block, virtually all of the lipid-mixing appears to be restricted
to the outer leaﬂets [2]. As hemifused intermediates may even
be somewhat reversible [66], relatively small shifts in assembly
energies could tip the balance towards or away from full fu-
sion. Synaptotagmin alone has only a modest (if any) eﬀect
on this process [28,67], consistent with the observation that
the clamped intermediate state requires complexin. Com-
plexin-induced hemifusion was not observed in the ﬂipped-Fig. 4. The clamped SNAREpin. This schematic representation of the fusio
molecular composition of the prefusion structure. (1) To what extent are th
before the calcium inﬂux? (2) How does the central helix of complexin (red) pr
free synaptotagmin (orange) interact? (4) What roles do distinct populations
play? In particular, how does the dynamic population of phosphoinositides m
present, for example, interacting with the N-terminal Habc regulatory domaiSNARE assay [1], perhaps reﬂecting crucial diﬀerences in the
baseline energetics or membrane conformations of the two sys-
tems. As more fusion platforms become available, the general-
ity of this regulatable hemifusion state must be determined.
Second, there are obvious protein diﬀerences in the assays,
including the complexin isoforms(s) under study and the pre-
cise sequence/tags of the SNAREs. Finally, it is worth noting
that the two assays rely upon diﬀerent readouts for real-time
measurement (lipid-mixing for the liposome assay and con-
tents-mixing in the form of cytosolic transfer of dsRED pro-
teins for the cell–cell assay (Fig. 2)). Thus, if the fusion pore
expands slowly or ﬂickers, then the mixing of ﬂuorescently la-
beled proteins in the cell–cell assay will necessarily be slow.
Additionally more work is needed to clarify the conse-
quences of adding proteins to a progressing liposome assay,
where SNAREs are in various states of assembly. As of yet,
no one has shown what happens when synaptotagmin plus cal-
cium is added to a typical SNARE fusion liposome assay after
some of the SNAREs have already engaged. It is possible that
some of the very rapid activation seen after adding synaptotag-
min/calcium in the liposome assay reﬂects an intrinsic activity
of synaptotagmin and is not limited to the complexin clamped
state. This is not the case in the ﬂipped-SNARE assay where
synaptotagmin alone is without eﬀect (presumably because
the appropriate lipids are missing).
Do the clamp and the calcium sensor coordinate to inﬂuence
SNARE assembly prior to the calcium inﬂux? There is no bio-
chemical evidence of a direct complexin–synaptotagmin interac-
tion. A larger complex including complexin, synaptotagmin and
the SNAREs has been reported in immunoprecipitation exper-
iments [30], butmore recent studies from the same group call this
result into question [3], as binding of either complexin or synapt-
otagmin to cis-SNARE complexes is mutually exclusive (dis-
cussed more below). The clamped intermediate, however, is a
membrane-bridging SNAREpin (Fig. 4). Biochemical charac-
terization of SNAREpin intermediates is inherently challenging,
due to the transitional nature and relative scarcity of thesen intermediate illustrates many of the unresolved questions about the
e SNAREs (green-syntaxin, blue-VAMP2, brown-SNAP-25) zippered
event further SNARE assembly? (3) With which proteins does calcium-
of anionic lipids on the vesicle (yellow) and plasma membrane (cyan)
odulate SNAREpin assembly? (5) What other proteins might also be
n of syntaxin (green ball)?
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either have not entered into a SNAREpin structure or will have
already proceeded through to the stable post-fusion cis-SNARE
complex). Giraudo et al. use their functional assay to establish
that the pre-calcium intermediate must be associated with both
complexin and synaptotagmin [1]. In fact, whereas complexin I
is an intrinsically unstable clamp (and requires membrane-
anchoring to achieve complete inhibition of fusion), the combi-
nation of complexin I and calcium-free synaptotagmin results in
a persistent inhibition, even after removal of the GPI anchor.
The clamp stabilizing capability of synaptotagmin is only evi-
dent when synaptotagmin is located on the same membrane as
VAMP2, a topological restriction that mimics the in vivo cir-
cumstance. Thus geometry and protein conformation are every
bit as important as protein composition in determining the sta-
bility of the clamped state.
One way calcium-bound synaptotagmin might trigger fusion
from the clamped intermediate is by physically displacing the
complexin from the SNAREs. The Sudhof lab has shown that
in detergent, synaptotagmin and complexin I compete for
binding to either brain-derived or recombinant cis-SNARE
complexes [3]. This competition is relatively calcium-insensi-
tive leading the authors to speculate that certain biochemical
characteristics of the regulatory machinery (like calcium sensi-
tivity) may only become apparent once the principle constitu-
ents are membrane associated. Indeed, once the cis-SNAREs
are reconstituted into supported bilayers, only calcium-associ-
ated synaptotagmin can eﬃciently displace complexin from the
SNARE complex (with as little as 50 nM calcium releasing
50% of the complexin) [3]. In contrast, when the SNAREs
are anchored instead to liposomal membranes, an apparent
complex of all ﬁve proteins (three SNAREs, complexin and
synaptotagmin) can be isolated [2]. As with the fusion assays
above, there are many distinguishing aspects of these two stud-
ies, including protein and lipid composition, which will have to
be explored to explain the apparent discrepancy. Nonetheless,
functional readouts both in vivo and in vitro indicate that
when the local concentration of complexin is kept artiﬁcially
high by membrane or SNARE-directed tethers, the clamp state
persists, regardless of calcium or synaptotagmin [1,3]. Thus the
subsequent activation of the SNARE complex likely requires a
freely diﬀusible complexin, with clamp relief deriving from
either conformational rearrangements or outright release of
complexin.9. Conclusions and future perspectives
The primary consequence of complexin binding is inhibitory:
the fusion complexes do not progress in vitro or in vivo [1–3],
and thus complexin constitutes a clamp. Whether complexin
might also promote SNAREpin zippering, helping to over-
come a protein folding energetic barrier, remains unknown.
Neither the order of events leading to its assembly, nor the
molecular architecture of the clamped SNAREpin is well-de-
scribed, but we can begin to develop a working model. (1)
The SNAREs begin to assemble, in a directed amino-to-car-
boxyl zippering which results in a partially zippered four helix
bundle. (2) Complexin captures this intermediate. At this stage
of SNARE-assembly, sequences in the membrane-proximal
carboxyl third of the VAMP2 SNARE domain remain accessi-ble to neurotoxins both in vivo and in vitro [1,13]. In the sim-
plest terms, this intermediate would be a partially assembled
SNAREpin, although in principle it may represent a speciﬁc
oligomeric assembly of SNAREpins, constituting a sort of
pre-fusion fusion pore. (3) Synaptotagmin binds this interme-
diate, stabilizing an otherwise weak interaction between com-
plexin and the trans-SNAREs and constitutes part of the
clamp. The actual order of addition (complexin vs. synapto-
tagmin) remains to be determined, but both in vitro studies
indicate that complexin is fully-suﬃcient to block SNARE
progression, provided the local concentration is relatively high.
(4) The vesicle and target membranes are now in very close
apposition, possibly even hemifused, and primed for fusion.
(5) Calcium-binding to synaptotagmin releases the complexin
clamp, and also catalyzes completion of fusion via synaptotag-
min–lipid or synaptotagmin–SNARE interactions. In this re-
gard, synaptotagmin may play three distinct roles: to sense
calcium via its C2 domains, to competitively remove the com-
plexin clamp, and to directly facilitate faster SNARE-depen-
dent fusion.References
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